Differential effects of DRB1*0301 and DQA1*0501- DQB1*0201 on the activation and progression of islet cell autoimmunity

Genes and Immunity

Volumn 8, Issue 8, 2007, Pages 628-633

  Eller, E ^a   Vardi, P ^b   McFann, K K ^a   Babu, S R ^a   Yu, L ^a   Bugawan, T L ^c   Erlich, H A ^c   Eisenbarth, G S ^a   Fain, P R ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; PANCREAS ISLET CELL; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ARABS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED;

EID: 36949040855     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364425     Document Type: Article

References (43)

1. Pietropaolo M, Eisenbarth G. Autoantibodies in human diabetes. Curr Dir Autoimmun 2001; 4: 252-282.
2. Campbell I, Harrison L. Molecular pathology of type 1 diabetes. Mol Biol Med 1990; 7: 299-309.
3. Kawasaki E, Eisenbarth G. High-throughput radioassays for autoantibodies to recombinant autoantigens. Front Biosci 2000; 5: E181-E190.
4. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes 2005; 54: S25-S31.
5. Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 2005; 54: S52-S61.
6. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 2005; 54: S62-S67.
7. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004; 89: 3896-3902.
8. Thomson G, Robinson W, Kuhner M, Joe S, MacDonald M, Gottschall J et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988; 43: 799-816.
9. Noble J, Waldes A, Cook M, Klitz W, Thomson G, Erlich H. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1148.
10. Caillat-Zucman S, Garchon H-J, Timsit J, Assan R, Boitard C, Dijilah-Saiah I et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-2250.
11. Hosszufalusi N, Vatay A, Rajczy K, Prohaszka Z, Pozsonyi E, Horvath L et al. Similar genetic features and different islet cell autoantibody pattern of Latent Autoimmune Diabetes in Adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003; 26: 452-457.
12. Mrena S, Savola K, Kulmala P, Reijonen H, Ilonen J, Akerblom HK et al. Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children. J Clin Endocrinol Metab 2003; 88: 2682-2689.
13. Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C et al. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clinl Endocrinol Metab 2006, 91: 1705-1713.
14. Nepom B, Nepom G, Coleman M, Kwok W. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci USA 1996; 93: 7202-7206.
15. Nepom G. Class II antigens and disease susceptibility. Ann Rev Med 1995; 46: 17-25.
16. Nepom GT. Conversations with GAD. J Autoimmun 2003; 20: 195-198.
17. Kwok W, Domeier M, Raymond F, Byers P, Nepom. G. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 1996; 156 2171-2177.
18. Florez J, Hirschhorn J, Altshuler D. The inherited basis of diabetes mellitus: Implications for the genetic analysis of complex triats. Annu Rev Genomics Hum Genet 2003; 4: 257-291.
19. Larsen CE, Alper CA. The genetics of HLA-associated disease. Curr Opin Immunol 2004; 16: 660-667.
20. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok C et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-274.
21. Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM et al. New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 2003; 62: 296-307.
22. Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA et al. Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 Haplotype. Diabetes 2006; 55: 1265-1269.
23. Palmer JP, Hirsch IB. What's in a name: Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes. Diabetes Care 2003; 26: 536-538.
24. Verge C, Vardi P, Babu S, Bao F, Erlich H, Bugawan T et al. Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J Invest 1998; 102: 1569-1575.
25. Bugawan T, Erlich H. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenet 1991; 33: 163-170.
26. Scharf S, Griffith R, Erlich H. Rapid typing; of DNA sequence polymorphisin at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol 1991; 30 190-201.
27. Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 2001; 62: 1234-1238.
28. Cucca F, Muntoni F, Lampis R, Frau F, Argiolas L, Silvetti M et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94.
29. Bugawan TL, Klitz W, Alejandrino, M, Ching J, Panelo A, Solfelix CM et al. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 2002; 59: 452-469.
30. Lie BA, Thorsby E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol 2005; 17:526-531.
31. Savola K, Bonifacio E, Sabbah E, Kuhnala P, Vahasalo P, Karjalainen J et al. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998; 41: 424-429.
32. Rolandsson O, Hagg E, Janer M, Rutledge E, Gaur LK, Nilsson M et al. High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA-4 or INS VNTF, J Intern Med 2003; 253: 447-453.
33. Sheehy M, Scharf S, Rowe J, Neme de, Gimenez M, Meske L, Erlich H et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989; 83 830-835.
34. Greenbaum CJ, Gaur LK, Noble JA. ICA+ relatives with DQA1*0102/ DQB1*0602 have expected 0602 sequence and DR' types. J Autoimmun 2002; 18: 67-70.
35. Greenbaum CJ, Eisenbarth G, Atkinson M, Yu L, Babu S, Schatz D et al. High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the diabetes prevention trial - type 1 diabetes. Diabetologia 2005; 48: 68-74.
36. Mrena S, Savola K, Kulmala P, Akerblom H, Knip M, the Childhood Diabetes in Finland Study Group. Staging of preclinical type 1 diabetes in siblinp of affected children. Pediatrics 1999; 104: 925-930.
37. Eller E, Vardi P, Babu S, Bugawan T, Erlich H, Yu L et al. Celiac disease and HLA. in a Bedouin kindred. Hum Immunol 2006; 67: 940-950.
38. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001; 17: 93-100.
39. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993; 53: 150-167.
40. Cordell JH, Clayton D. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data. Application to HLA in Type 1 Diabetes. Am J Hum Genet 2002; 70: 124-141.
41. McQueen M, Weiss S, Laird, M, Lange C. On the parsing of statistical information in family-based association testing. Nat Genet 2007; 39: 281-282.
42. Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004; 429: 475-477.
43. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006; 7: 812-820.